1.A multicenter study on diagnosing clinically significant prostate cancer using a deep learning classification model based on biparametric MRI
Lin LI ; Man LI ; Saiqun LÜ ; Jieke LIU ; Shengbin DENG ; Qiang ZHANG ; Tao PENG
Journal of Practical Radiology 2025;41(7):1163-1167
Objective To investigate the classification capability of a deep learning classification model based on biparametric mag-netic resonance imaging(bpMRI)for clinically significant prostate cancer(csPCa)and clinically insignificant prostate cancer(cisPCa).Methods A retrospective analysis was conducted on the data of 565 prostate bpMRI patients.A deep learning classification model was established for csPCa.The patients were randomly divided into training set(452 cases)and internal test set(113 cases)at a ratio of 8︰2.Internal validation was performed,followed by external validation(external validation set)using data from 120 patients across four different hospitals.The area under the curve(AUC)of the receiver operating characteristic(ROC)curve,F1 score,precision,sensi-tivity,specificity,accuracy,and calibration curves were used to evaluate the model.Decision curve analysis(DCA)was also applied to assess the clinical benefit of the model.Results The deep learn-ing classification model for csPCa classification demonstrated the following performance across the training set,internaltest set,and external validation set:sensitivity of 0.986,0.887,and 0.750;specificity of 0.967,0.850,and 0.976;precision of 0.963,0.839,and 0.818;accuracy of 0.974,0.862,and 0.792;F1 score of 0.974,0.862,and 0.783;and AUC of 0.998,0.896,and 0.883,respec-tively.The calibration curves for all three datasets showed high consistency between predicted and actual probabilities.DCA indicated that the highest net benefit threshold probabilities for the training set,internal test set,and external validation set were 0.2-0.7,0.2-0.6,and 0.2-0.5,respectively.Conclusion The deep learning classification model demonstrated excellent performance in classifying csPCa and exhibited good generalizability,which is worhty of clinical application.
2.A multicenter study on diagnosing clinically significant prostate cancer using a deep learning classification model based on biparametric MRI
Lin LI ; Man LI ; Saiqun LÜ ; Jieke LIU ; Shengbin DENG ; Qiang ZHANG ; Tao PENG
Journal of Practical Radiology 2025;41(7):1163-1167
Objective To investigate the classification capability of a deep learning classification model based on biparametric mag-netic resonance imaging(bpMRI)for clinically significant prostate cancer(csPCa)and clinically insignificant prostate cancer(cisPCa).Methods A retrospective analysis was conducted on the data of 565 prostate bpMRI patients.A deep learning classification model was established for csPCa.The patients were randomly divided into training set(452 cases)and internal test set(113 cases)at a ratio of 8︰2.Internal validation was performed,followed by external validation(external validation set)using data from 120 patients across four different hospitals.The area under the curve(AUC)of the receiver operating characteristic(ROC)curve,F1 score,precision,sensi-tivity,specificity,accuracy,and calibration curves were used to evaluate the model.Decision curve analysis(DCA)was also applied to assess the clinical benefit of the model.Results The deep learn-ing classification model for csPCa classification demonstrated the following performance across the training set,internaltest set,and external validation set:sensitivity of 0.986,0.887,and 0.750;specificity of 0.967,0.850,and 0.976;precision of 0.963,0.839,and 0.818;accuracy of 0.974,0.862,and 0.792;F1 score of 0.974,0.862,and 0.783;and AUC of 0.998,0.896,and 0.883,respec-tively.The calibration curves for all three datasets showed high consistency between predicted and actual probabilities.DCA indicated that the highest net benefit threshold probabilities for the training set,internal test set,and external validation set were 0.2-0.7,0.2-0.6,and 0.2-0.5,respectively.Conclusion The deep learning classification model demonstrated excellent performance in classifying csPCa and exhibited good generalizability,which is worhty of clinical application.
3.Analysis of risk factors for recurrence after unilateral biportal endoscopy in patients with lumbar disc herniation
Qiang LÜ ; Rui LIU ; Shenpeng LIU
China Journal of Endoscopy 2024;30(3):47-51
Objective To explore the risk factors for recurrence after unilateral biportal endoscopy in patients with lumbar disc herniation.Methods Clinical data of 156 patients with lumbar disc herniation were retrospectively analyzed.All the patients underwent unilateral biportal endoscopy treatment.Follow up for 2 years after surgery,and the recurrence rate of all patients was recorded.The clinical characteristics of patients in the recurrent and non recurrent groups were compared,the factors influencing postoperative recurrence were analyzed by multivariate Logistic regression.Results After a 2-year follow-up,a total of 22 patients experienced recurrence,with a recurrence rate of 14.10%(22/156).The results of multivariate Logistic analysis showed that,the age>60 years old,fiber ring break>5 mm,incomplete nucleus pulposus removal,and postoperative intervertebral motion>10 ° were independent risk factors for recurrence after unilateral biportal endoscopy in patients with lumbar disc herniation(P<0.05).Conclusion Age>60 years old,fiber ring break>5 mm,incomplete removal of the nucleus pulposus,and postoperative intervertebral motion>10 ° were independent risk factors for recurrence after unilateral biportal endoscopy in patients with lumbar disc herniation,and prevention should be strengthened.
4.Analysis of the mechanisms of Guanxinning Tablet for antithrombotic and microthrombotic effects caused by COVID-19 based on network pharmacology
Pei-yu GONG ; Guang-xu XIAO ; Wen-jun LI ; Guan-wei FAN ; Ming LÜ ; Jin-qiang ZHU
Acta Pharmaceutica Sinica 2024;59(9):2545-2555
Thrombosis is a key factor that increases the mortality rate of COVID-19 patients and causes long COVID sequelae. Guanxinning Tablet (GXNT), which is composed of
5.Pharmacokinetics study of single and multiple doses of azvudine in healthy young and elderly subjects
Yu ZHANG ; Xiao-Jian LIU ; Hao-Shuang JU ; Bin-Yuan HE ; Yuan-Hao WAN ; Li-Wei CHAI ; Le-Yang REN ; Min LÜ ; Ya-Qiang JIA ; Wei ZHANG ; Ping XU
The Chinese Journal of Clinical Pharmacology 2024;40(9):1316-1320
Objective To evaluate the pharmacokinetic characteristics and safety of single and multiple oral azvudine tablets in healthy young and elderly Chinese subjects.Methods This was a open-label and parallel-group study.The trial consisted of two groups:healthy young subjects group and healthy elderly subjects group,with 12 subjects in each group.Enrolled subjects were first given a single dose,fasting oral azvudine tablet 5 mg,after a 3-day cleansing period entered the multiple dose phase,fasting oral azvudine tablet 5 mg·d-1 for 7 days.Results After a single dose of azvudine 5 mg,Cmax and AUC0-∞ were(4.76±2.12)ng·mL-1,(6.53±2.20)ng·mL-1·h,and Tmax,t1/2 were 0.75,1.87 h in young subjects;Cmax and AUC0-∞ were(6.40±3.25)ng·mL-1,(9.50±3.70)ng·mL-1·h,and Tmax,t1/2 were 0.63,2.66 h in elderly subjects.After a multiple dose of azvudine 5 mg·d-1 for 7 d,Cmax and AUC0-∞ were(3.26±1.61)ng·mL-1,(5.38±2.19)ng·mL-1·h,and Tmax,ss,t1/2,ss were 0.88,2.13 h in young subjects;Cmax,ss and AUC0-∞,ss were(3.97±2.09)ng·mL-1,(6.71±3.26)ng·mL-1·h,and Tmax,ss,t1/2,ss were 0.75,2.56 h in elderly subjects.Elderly/young geometric mean ratios and 90%CIs were 128.37%(88.23%-186.76%),139.93%(105.42%-185.72%),140.03%(106.33%-184.41%)for azvudine Cmax,AUC0-t,AUC0-∞ after a single dose,and were 118.66%(80.83%-174.20%),118.41%(83.60%-167.69%),118.95%(84.78%-166.89%)for azvudine Cmax,AUC0-t,AUC0_∞ after a multiple dose of azvudine 5 mg·d-1 for 7 d.Conclusion After single and multiple oral administration of azvudine tablets,systemic exposure to azvudine was higher in healthy elderly subjects compared with healthy young subjects.After taking azvudine tablets,the types,severity and incidence of adverse events and adverse drug reactions in healthy elderly people were not significantly different from those in healthy young subjects.Azvudine was found to be safe and well tolerated in healthy elderly subjects.
6.A single-center study on the safety and effectiveness of a novel non-implant interatrial shunt device
San-Shuai CHANG ; Xin-Min LIU ; Zheng-Ming JIANG ; Yu-Tong KE ; Qian ZHANG ; Qiang LÜ ; Xin DU ; Jian-Zeng DONG ; Guang-Yuan SONG
Chinese Journal of Interventional Cardiology 2024;32(8):425-433
Objective To preliminarily evaluate the safety and effectiveness of a novel non-implantable atrial shunt device based on radiofrequency ablation for the treatment of chronic heart failure(CHF).Methods This was a prospective single-arm study.From January 2023 to December 2023,five eligible CHF patients were consecutively enrolled at Beijing Anzhen Hospital,Capital Medical University,and underwent inter-atrial shunt using Shenzhen Betterway atrial shunt device.Pulmonary capillary wedge pressure(PCWP),right atrial pressure(RAP),pulmonary artery pressure(PAP),total pulmonary resistance(TPR),pulmonary vascular resistance(PVR),and pulmonary/systemic blood flow ratio(Qp/Qs)were measured using right heart catheterization before and immediately after procedure.Patients were followed up for 90 days,and echocardiography,right heart catheterization,and cardiac functional indicators were evaluated.The primary endpoint was procedural success.Secondary endpoints included clinical success,echocardiographic changes,6-minute walk distance(6MWD)changes,New York Heart Association(NYHA)class changes,Kansas city cardiomyopathy questionnaire(KCCQ)score changes,and amino-terminal probrain natriuretic peptide(NT-proBNP)level changes at 90 days.The safety endpoint was major cardiovascular and cerebrovascular adverse events and device-related adverse events.Results All five patients successfully achieved left-to-right atrial shunt.Compared with baseline,PCWP decreased significantly immediately after procedure in all five patients,with a procedural success rate of 100%.There were no significant changes in RAP,PAP,TPR,and PVR before and immediately after procedure.After 90 days follow-up,four patients had persistent left-to-right atrial shunt,and PCWP was significantly lower than baseline,with a clinical success rate of 80%.Compared with baseline,LVEF increased,left ventricular end-diastolic diameter decreased,and tricuspid annular plane systolic excursion and right ventricular fractional area change were not impaired in all five patients at 90 days.KCCQ scores and 6MWT improved,NT-proBNP decreased,and NYHA class did not change significantly.There were no deaths,rehospitalizations for heart failure,stroke-related adverse events,or device-related adverse events during the follow-up.Conclusions The novel non-implantable atrial shunt catheter can safely and effectively improve hemodynamic,echocardiographic,and cardiac functional indicators in patients with heart failure.However,larger-scale clinical studies are still needed to validate its long-term clinical effectiveness.
7.Retrospective study of radiofrequency catheter ablation in patients with heart failure and atrial fibrillation
Yu-ling XIONG ; Zhi-yan WANG ; Chang HUA ; Yang-yang TANG ; Xin-ru LIU ; Qiang LÜ ; Jian-zeng DONG ; Xin DU
Chinese Journal of Interventional Cardiology 2024;32(12):683-688
Objective To explore the safety and efficacy of radiofrequency catheter ablation(RCFA)in patients with persistent atrial fibrillation(AF)/atrial flutter(AFL)and heart failure(HF)with left ventricular ejection fraction≤35%.Methods This study is a retrospective study.Patients with persistent AF/AFL and HF with left ventricular ejection fraction≤ 35%admitted to Beijing Anzhen Hospital from January 2018 to March 2024 were enrolled.The perioperative characteristics and complications changes in echocardiographic parameters,and follow-up outcomes were analyzed.Results A total of 45 patients were enrolled with a mean age of(56±13)years and a mean LVEF of(28±4)%.The ablation strategy was circumferential pulmonary vein isolation and empirical linear ablation.The operation time and fluoroscopy time were 120(120,163)min and 5(4,10)min respectively.The patients mainly underwent linear ablation including circumferential pulmonary vein isolation(38,84.4%),cavotricuspid isthmus(37,82.2%),roofline(34,75.6%),mitral isthmus(34,75.6%).21(46.7%)patients underwent ehtanol infusion into the vein of Marshall.24(53.3%)patients underwent electrocardioversion.All patients restored sinus rhythm immediately after RFCA and had no perioperative complications.After a median follow-up of 22.9(7.8,31.0)months,2 patients died of cardiovascular disease,1 patient underwent heart transplantation,14(33.3%)patients were readmitted for cardiovascular disease,and 10 patients(23.8%)had recurrence of AF.The mean LVEF of the 28 patients who obtained LVEF at the last follow-up increased from(28±4)%to(51±14)%,and the average improvement of LVEF was(23±13)%(P<0.0001).15 of these patients had complete recovery of left ventricular systolic function(LVEF≥ 50%).Conclusions RFCA is safe and effective for patients with persistent AF/AFL and HF with LVEF ≤ 35%,and can improve patient's cardiac function and significantly increase LVEF.
8.Retrospective study of radiofrequency catheter ablation in patients with heart failure and atrial fibrillation
Yu-ling XIONG ; Zhi-yan WANG ; Chang HUA ; Yang-yang TANG ; Xin-ru LIU ; Qiang LÜ ; Jian-zeng DONG ; Xin DU
Chinese Journal of Interventional Cardiology 2024;32(12):683-688
Objective To explore the safety and efficacy of radiofrequency catheter ablation(RCFA)in patients with persistent atrial fibrillation(AF)/atrial flutter(AFL)and heart failure(HF)with left ventricular ejection fraction≤35%.Methods This study is a retrospective study.Patients with persistent AF/AFL and HF with left ventricular ejection fraction≤ 35%admitted to Beijing Anzhen Hospital from January 2018 to March 2024 were enrolled.The perioperative characteristics and complications changes in echocardiographic parameters,and follow-up outcomes were analyzed.Results A total of 45 patients were enrolled with a mean age of(56±13)years and a mean LVEF of(28±4)%.The ablation strategy was circumferential pulmonary vein isolation and empirical linear ablation.The operation time and fluoroscopy time were 120(120,163)min and 5(4,10)min respectively.The patients mainly underwent linear ablation including circumferential pulmonary vein isolation(38,84.4%),cavotricuspid isthmus(37,82.2%),roofline(34,75.6%),mitral isthmus(34,75.6%).21(46.7%)patients underwent ehtanol infusion into the vein of Marshall.24(53.3%)patients underwent electrocardioversion.All patients restored sinus rhythm immediately after RFCA and had no perioperative complications.After a median follow-up of 22.9(7.8,31.0)months,2 patients died of cardiovascular disease,1 patient underwent heart transplantation,14(33.3%)patients were readmitted for cardiovascular disease,and 10 patients(23.8%)had recurrence of AF.The mean LVEF of the 28 patients who obtained LVEF at the last follow-up increased from(28±4)%to(51±14)%,and the average improvement of LVEF was(23±13)%(P<0.0001).15 of these patients had complete recovery of left ventricular systolic function(LVEF≥ 50%).Conclusions RFCA is safe and effective for patients with persistent AF/AFL and HF with LVEF ≤ 35%,and can improve patient's cardiac function and significantly increase LVEF.
9.Clinical observation on Yi Jin Jing(Sinew-transforming Qigong Exercises)in improving anxiety for asymptomatic patients with COVID-19 infection during quarantine
Hua XING ; Xiaojie SU ; Xuqiu SUN ; Sheng SHAO ; Yiming SHAN ; Yazhou LI ; Chao ZHOU ; Weicong ZHENG ; Fanchao MENG ; Qiang LÜ ; Wuquan SUN ; Li GONG ; Fuqing ZHANG
Journal of Acupuncture and Tuina Science 2023;21(4):285-293
Objective:To observe the effect of Yi Jin Jing(Sinew-transforming Qigong Exercises)intervention on anxiety in asymptomatic patients with Corona Virus Disease 2019(COVID-19)infection during quarantine.Methods:A total of 160 asymptomatic patients with COVID-19 infection were stratified by gender and divided into an observation group and a control group by the stratified randomization method,with 80 cases in each group.The control group was given basic nursing in the cabin,and the observation group was given additional Yi Jin Jing exercises once a day,20 min each time,and trained continuously until 1 d before leaving the cabin.The Hamilton anxiety scale(HAMA)score was compared between the two groups.Results:A total of 154 cases were included for data analysis in this study,including 74 cases in the observation group and 80 cases in the control group.After intervention,the HAMA scores in both groups increased(P<0.05),while the score in the observation group was lower than that in the control group(P<0.05).In the control group,the HAMA score of females after intervention was higher than that of males.The scores of mental anxiety and somatic anxiety in both groups were higher than those before intervention,while the score of mental anxiety in the observation group was significantly lower than that in the control(P<0.05).However,there was no statistical difference in the somatic score between the two groups(P>0.05).Conclusion:Patients with COVID-19 infection will get anxious during quarantine.Yi Jin Jing exercise can effectively reduce the aggravation of anxiety in asymptomatic patients with COVID-19 infection during concentrated quarantine.
10.Introduction to revision of Technical Specification for Occupational Health Surveillance
Chen YU ; Dehong LI ; Daoyuan SUN ; Zubing WANG ; Chaoqiang JIANG ; Xunmiao ZHANG ; Yongjian YAN ; Weiming YUAN ; Yiqun XUAN ; Xin QIAO ; Yujing XIA ; Qiuhong ZHU ; Qiang HOU ; Hong WANG ; Yiwen JIANG ; Xuetao ZHANG ; Fang QI ; Xiangpei LÜ ; Huanqiang WANG
China Occupational Medicine 2023;50(2):209-216
To revise GBZ 188 Technical Specification for Occupational Health Surveillance based on national laws, regulations, standards, specifications and legal documents of occupational disease, and combination with the actual situation in China. The main modifications are as follows: the occupational health surveillance for workers exposed to toluene (xylene may implement by reference), bromopropane, methyl iodide, ethylene oxide, chloroacetic acid, indium and its compounds, coal tar, coal tarasphalt, asphalt, β-naphthylamine, dust of metal and its compounds(tin, iron, antimony, barium and its compounds), hard metal dust, erionite dust, low temperature, laser, tick-borne encephalitis virus, Borrelia burgdorferi, and human immunodeficiency virus, for scraper or grind operators, and underground workers using squatting or kneeling position, crawling position, side-lying position, or shoulder position for a long period of time are included. The emergency health screening for workers exposed to arsenic, fluorine and its inorganic compounds, and acrylamide are included. The occupational medical examination (OME) for workers exposed to amino and nitro compounds of benzene, phosgene, monomethylamine, organic fluorine and dimethyl sulfate has been adjusted and made mandatory, with corresponding assessments required upon leaving the job. The special occupational health surveillance for workers exposed to mycobacterium tuberculosis and hepatitis virus is removed. The OME conclusion of reexamination is removed, and standardize recheck/additional inspection requirements. The optional items in OME performed before, during and after leaving post are removed, but the optional items in emergency medical examination are retained. Additional OME items are added. The Guideline for OME Summary Reports is added as informative appendix, and so on. The revised GBZ 188 Technical Specification for Occupational Health Surveillance is more scientific and practical.

Result Analysis
Print
Save
E-mail